Fig. 1
From: Clinical characteristics and prognostic factors of Hurthle cell carcinoma: a population based study
Survival analysis. (a) Cancer-specific survival of the patients. (b) Cancer-specific survival of patients under and over 45 years of age (P = 0.007). (c) Cancer-specific survival of patients with different SEER stages (P < 0.001). (d) Cancer-specific survival of patients with different lymph node status (P < 0.001). (e) Cancer-specific survival of patients with different T stages (P < 0.001). (F) Cancer-specific survival of surgically and non-surgically managed patients (P < 0.001)